Austin

Governor Abbott Appoints Wynne and Comer to Texas Council on Alzheimer's Disease and Related Disorders

AI Assisted Icon
Published on November 11, 2025
Governor Abbott Appoints Wynne and Comer to Texas Council on Alzheimer's Disease and Related DisordersSource: Office of the Texas Governor

Governor Greg Abbott has made his choices to bolster the Texas Council on Alzheimer's Disease and Related Disorders by appointing two new members who will serve until the end of August 2031. These appointments include D. Bailey Wynne, a teaching fellow and doctoral student deeply immersed in the healthcare field, and Kathey Comer, a retired professional with a background that spans various sectors, including government service and non-profit organizations.

As reported by the Texas Governor's Office, Wynne's expertise in pharmacy and health system management, enriched by her education from Creighton University and several Texas institutions, positions her as a key figure in strategizing state services for those affected by Alzheimer's and related diseases. Her engagement extends beyond academia into community planning and finance, indicating a multifaceted approach to her responsibilities on the council.

Comer brings to the table a tapestry of experience, particularly in gerontology, which is a direct implication in her new role on the council. With a storied career that includes involvement with U.S. Senator John Cornyn's office and leadership roles in the building industry, Comer's diverse skill set is likely to infuse the council with a broader perspective. Her commitment is also evidenced by her participation in civic groups like Catalyst 100 and her ongoing volunteer work.

Both appointees are expected to contribute to the Council's agenda of improving coordination of state services for persons with Alzheimer's disease and akin disorders. As the state faces the complex challenges of an increasing population needing specialized care, the expertise of Wynne and Comer will be instrumental in shaping Texas's response to this growing healthcare concern. Their terms, which will not expire until after a nearly six-year period, provide ample time for them to make significant impacts in their respective roles.